258 related articles for article (PubMed ID: 28403589)
1. The efficacy of an association of palmitoylethanolamide and alpha-lipoic acid in patients with chronic prostatitis/chronic pelvic pain syndrome: A randomized clinical trial.
Giammusso B; Di Mauro R; Bernardini R
Arch Ital Urol Androl; 2017 Mar; 89(1):17-21. PubMed ID: 28403589
[TBL] [Abstract][Full Text] [Related]
2. Flower Pollen Extract in Association with Vitamins (Deprox 500®) Versus Serenoa repens in Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Comparative Analysis of Two Different Treatments.
Macchione N; Bernardini P; Piacentini I; Mangiarotti B; Del Nero A
Antiinflamm Antiallergy Agents Med Chem; 2019; 18(2):151-161. PubMed ID: 30488800
[TBL] [Abstract][Full Text] [Related]
3. Treatment of chronic prostatitis/chronic pelvic pain syndrome category IIIA with Serenoa repens plus selenium and lycopene (Profluss) versus S. repens alone: an Italian randomized multicenter-controlled study.
Morgia G; Mucciardi G; Galì A; Madonia M; Marchese F; Di Benedetto A; Romano G; Bonvissuto G; Castelli T; Macchione L; Magno C
Urol Int; 2010; 84(4):400-6. PubMed ID: 20332612
[TBL] [Abstract][Full Text] [Related]
4. Eviprostat has an identical effect compared to pollen extract (Cernilton) in patients with chronic prostatitis/chronic pelvic pain syndrome: a randomized, prospective study.
Iwamura H; Koie T; Soma O; Matsumoto T; Imai A; Hatakeyama S; Yoneyama T; Hashimoto Y; Ohyama C
BMC Urol; 2015 Dec; 15():120. PubMed ID: 26643109
[TBL] [Abstract][Full Text] [Related]
5. Comparison of cernitin pollen extract vs tadalafil therapy for refractory chronic prostatitis/chronic pelvic pain syndrome: A randomized, prospective study.
Matsukawa Y; Naito Y; Funahashi Y; Ishida S; Fujita T; Tochigi K; Kato M; Gotoh M
Neurourol Urodyn; 2020 Sep; 39(7):1994-2002. PubMed ID: 32648985
[TBL] [Abstract][Full Text] [Related]
6. The role of nutraceutical medications in men with non bacterial chronic prostatitis and chronic pelvic pain syndrome: A prospective non blinded study utilizing flower pollen extracts versus bioflavonoids.
Maurizi A; De Luca F; Zanghi A; Manzi E; Leonardo C; Guidotti M; Antonaccio FP; Olivieri V; De Dominicis C
Arch Ital Urol Androl; 2019 Jan; 90(4):260-264. PubMed ID: 30655636
[TBL] [Abstract][Full Text] [Related]
7. A prospective, 1-year trial using saw palmetto versus finasteride in the treatment of category III prostatitis/chronic pelvic pain syndrome.
Kaplan SA; Volpe MA; Te AE
J Urol; 2004 Jan; 171(1):284-8. PubMed ID: 14665895
[TBL] [Abstract][Full Text] [Related]
8. Alfuzosin treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled, pilot study.
Mehik A; Alas P; Nickel JC; Sarpola A; Helström PJ
Urology; 2003 Sep; 62(3):425-9. PubMed ID: 12946740
[TBL] [Abstract][Full Text] [Related]
9. Fluoxetine ameliorates symptoms of refractory chronic prostatitis/chronic pelvic pain syndrome.
Xia D; Wang P; Chen J; Wang S; Jiang H
Chin Med J (Engl); 2011 Jul; 124(14):2158-61. PubMed ID: 21933619
[TBL] [Abstract][Full Text] [Related]
10. The efficacy and safety of Serenoa repens extract for the treatment of patients with chronic prostatitis/chronic pelvic pain syndrome: a multicenter, randomized, double-blind, placebo-controlled trial.
Zhang K; Guo RQ; Chen SW; Chen B; Xue XB; Chen S; Huang J; Liu M; Tian Y; Zuo L; Chen M; Zhou LQ
World J Urol; 2021 Sep; 39(9):3489-3495. PubMed ID: 33452912
[TBL] [Abstract][Full Text] [Related]
11. Comparison of transcutaneous tibial nerve stimulation versus percutaneous tibial nerve stimulation in category IIIB chronic prostatitis/chronic pelvic pain syndrome: A randomized prospective trial.
Sevim M; Alkiş O; Kartal İG; Kazan HO; İvelik Hİ; Aras B; Kabay Ş
Prostate; 2023 Jun; 83(8):751-758. PubMed ID: 36871235
[TBL] [Abstract][Full Text] [Related]
12. α-blockers, antibiotics and anti-inflammatories have a role in the management of chronic prostatitis/chronic pelvic pain syndrome.
Thakkinstian A; Attia J; Anothaisintawee T; Nickel JC
BJU Int; 2012 Oct; 110(7):1014-22. PubMed ID: 22471591
[TBL] [Abstract][Full Text] [Related]
13. Multimodal therapy for category III chronic prostatitis/chronic pelvic pain syndrome in UPOINTS phenotyped patients.
Magri V; Marras E; Restelli A; Wagenlehner FM; Perletti G
Exp Ther Med; 2015 Mar; 9(3):658-666. PubMed ID: 25667610
[TBL] [Abstract][Full Text] [Related]
14. Serenoa repens associated with selenium and lycopene extract and bromelain and methylsulfonylmethane extract are able to improve the efficacy of levofloxacin in chronic bacterial prostatitis patients.
Cai T; Tiscione D; Gallelli L; Verze P; Palmieri A; Mirone V; Bartoletti R; Malossini G
Arch Ital Urol Androl; 2016 Oct; 88(3):177-182. PubMed ID: 27711089
[TBL] [Abstract][Full Text] [Related]
15. Clinical efficacy of roxithromycin in men with chronic prostatitis/chronic pelvic pain syndrome in comparison with ciprofloxacin and aceclofenac: a prospective, randomized, multicenter pilot trial.
Choe HS; Lee SJ; Han CH; Shim BS; Cho YH
J Infect Chemother; 2014 Jan; 20(1):20-5. PubMed ID: 24462419
[TBL] [Abstract][Full Text] [Related]
16. Effect of Essential Oil on Patients with Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Pilot Randomized Controlled Trial.
Ying J; Zhou MJ; Chen HY; Chen L; Zhang W; Ji J; Yu C; Zhang ZJ
Chin J Integr Med; 2019 Feb; 25(2):91-95. PubMed ID: 29948596
[TBL] [Abstract][Full Text] [Related]
17. Treatment of chronic prostatitis/chronic pelvic pain syndrome with tamsulosin: a randomized double blind trial.
Nickel JC; Narayan P; McKay J; Doyle C
J Urol; 2004 Apr; 171(4):1594-7. PubMed ID: 15017228
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and Safety of Ningmitai Capsule in Patients With Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial.
Zhang K; Liu Y; Yang W; Wang J; Yang J; Zhang G; Bai W; Chen S
Urology; 2021 Jul; 153():264-269. PubMed ID: 33482135
[TBL] [Abstract][Full Text] [Related]
19. Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial.
Alexander RB; Propert KJ; Schaeffer AJ; Landis JR; Nickel JC; O'Leary MP; Pontari MA; McNaughton-Collins M; Shoskes DA; Comiter CV; Datta NS; Fowler JE; Nadler RB; Zeitlin SI; Knauss JS; Wang Y; Kusek JW; Nyberg LM; Litwin MS;
Ann Intern Med; 2004 Oct; 141(8):581-9. PubMed ID: 15492337
[TBL] [Abstract][Full Text] [Related]
20. Treatment of refractory category III nonbacterial chronic prostatitis/chronic pelvic pain syndrome with intraprostatic injection of onabotulinumtoxinA: a prospective controlled study.
Abdel-Meguid TA; Mosli HA; Farsi H; Alsayyad A; Tayib A; Sait M; Abdelsalam A
Can J Urol; 2018 Apr; 25(2):9273-9280. PubMed ID: 29680006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]